Regeneron Pharmaceuticals
REGN
NASDAQ
IPO1991
about REGN
Regeneron Pharmaceuticals is a leading biopharmaceutical company focused on researching, developing, and producing innovative medicines and genetic-based treatments, including its widely used treatment for eye diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $580.50 | $586.14 | $575.93 | $61.26B | 1.25M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$13.24 | 13.38 | 17.40 | 29.37% | 37.86% | 0.60% |